On May 7, 2025, the American College of Rheumatology (ACR) released the full guideline for diagnosing, monitoring, and treating lupus nephritis (LN), which appeared in Arthritis & Rheumatology.

The finding might ... For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete ...

Background The therapy of lupus nephritis remains toxic and only partially effective but the benefits ... While the initial biopsy confirms the diagnosis, nephritis class and other parameters, ...

Introduction and purpose Lupus nephritis (LN) is a major cause of morbidity and mortality ... SLE group (non-nephritis), LN group (LN class I–V). The tissue slides were heated at 60°C for 60 min, then ...